Body Dysmorphic Disorders

Phase 4 trials (3)

• levetiracetam
• fluoxetine
• venlafaxine

Phase 2 trials (4)

• oxytocin
• milk thistle
• psilocybin
• dextromethorphan

Phase 1 trials (1)

• cycloserine

Other trials (2)

• memantine
• diprenorphine

Organization Involved with Phase 4 Indications (5)

• Brown University
• Hoosier Cancer Research Network
• Icahn School of Medicine at Mount Sinai
• Food and Drug Administration
• Yeshiva University

Organization Involved with Phase 3 Indications (3)

• National Institute of Mental Health (NIMH)
• Harvard University
• Rhode Island Hospital

Organization Involved with Phase 2 Indications (4)

• Columbia University
• University of California, Los Angeles
• University of Chicago
• COMPASS Pathways

Organization Involved with Other Experimental Indications (3)

• Mclean Hospital
• University of Lyon
• Government of France